Literature DB >> 23202257

Health expenditure growth: looking beyond the average through decomposition of the full distribution.

Claudine de Meijer1, Owen O'Donnell, Marc Koopmanschap, Eddy van Doorslaer.   

Abstract

Explanations of growth in health expenditures have restricted attention to the mean. We explain change throughout the distribution of expenditures, providing insight into how expenditure growth and its explanation differ along the distribution. We analyse Dutch data on actual health expenditures linked to hospital discharge and mortality registers. Full distribution decomposition delivers findings that would be overlooked by examination of changes in the mean alone. The growth rate of hospital expenditures is greatest at the middle of the distribution and is driven mainly by changes in the distributions of determinants. Pharmaceutical expenditures increase most rapidly at the top of the distribution and are mainly attributable to structural changes, including technological progress, making treatment of the highest cost cases even more expensive. Changes in hospital practice styles make the largest contribution of all determinants to increased spending not only on hospital care but also on pharmaceuticals, suggesting important spill over effects.
Copyright © 2012 Elsevier B.V. All rights reserved.

Mesh:

Year:  2012        PMID: 23202257     DOI: 10.1016/j.jhealeco.2012.10.009

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  9 in total

1.  Health care expenditure disparities in the European Union and underlying factors: a distribution dynamics approach.

Authors:  José Villaverde; Adolfo Maza; María Hierro
Journal:  Int J Health Care Finance Econ       Date:  2014-05-14

2.  Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.

Authors:  Ya-Ming Liu
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

3.  Modeling the Dynamics of the U.S. Healthcare Expenditure Using a Hyperbolastic Function.

Authors:  J T Guemmegne; J-J Kengwoung-Keumo; M A Tabatabai; K P Singh
Journal:  Adv Appl Stat       Date:  2014-10

4.  Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy.

Authors:  Lars Børty; Rasmus F Brøndum; Heidi S Christensen; Charles Vesteghem; Marianne Severinsen; Søren P Johnsen; Lars H Ehlers; Ursula Falkmer; Laurids Ø Poulsen; Martin Bøgsted
Journal:  Eur J Health Econ       Date:  2022-08-26

5.  Effect of having private health insurance on the use of health care services: the case of Spain.

Authors:  David Cantarero-Prieto; Marta Pascual-Sáez; Noelia Gonzalez-Prieto
Journal:  BMC Health Serv Res       Date:  2017-11-13       Impact factor: 2.655

6.  Trends in and drivers of healthcare expenditure in the English NHS: a retrospective analysis.

Authors:  Idaira Rodriguez Santana; María José Aragón; Nigel Rice; Anne Rosemary Mason
Journal:  Health Econ Rev       Date:  2020-06-30

7.  Demand-side determinants of rising hospital admissions in Germany: the role of ageing.

Authors:  Jonas Krämer; Jonas Schreyögg
Journal:  Eur J Health Econ       Date:  2019-02-09

8.  Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition.

Authors:  Michael Stucki
Journal:  Eur J Health Econ       Date:  2021-01-12

9.  Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure.

Authors:  Mauro Laudicella; Paolo Li Donni; Kim Rose Olsen; Dorte Gyrd-Hansen
Journal:  Health Econ       Date:  2022-03-31       Impact factor: 2.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.